MRTX - Mirati Therapeutics EPS misses by $0.78 August, 05 2021 05:36 PM Mirati Therapeutics Inc. Mirati Therapeutics (NASDAQ:MRTX): Q2 GAAP EPS of -$3.23 misses by $0.78. Cash, cash equivalents, and short-term investments of $1.2B Press Release For further details see: Mirati Therapeutics EPS misses by $0.78